These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 11133812
1. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Zi X, Singh RP, Agarwal R. Carcinogenesis; 2000 Dec; 21(12):2225-35. PubMed ID: 11133812 [Abstract] [Full Text] [Related]
2. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A, Agarwal R, Agarwal C. Oncogene; 2003 Mar 06; 22(9):1302-16. PubMed ID: 12618755 [Abstract] [Full Text] [Related]
3. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells. Bhatia N, Agarwal R. Prostate; 2001 Feb 01; 46(2):98-107. PubMed ID: 11170137 [Abstract] [Full Text] [Related]
4. Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells. Sharma Y, Agarwal C, Singh AK, Agarwal R. Mol Carcinog; 2001 Apr 01; 30(4):224-36. PubMed ID: 11346885 [Abstract] [Full Text] [Related]
6. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Zi X, Grasso AW, Kung HJ, Agarwal R. Cancer Res; 1998 May 01; 58(9):1920-9. PubMed ID: 9581834 [Abstract] [Full Text] [Related]
11. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells. Tyagi A, Sharma Y, Agarwal C, Agarwal R. Pharm Res; 2008 Sep 01; 25(9):2143-50. PubMed ID: 18253818 [Abstract] [Full Text] [Related]
12. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Lin J, Adam RM, Santiestevan E, Freeman MR. Cancer Res; 1999 Jun 15; 59(12):2891-7. PubMed ID: 10383151 [Abstract] [Full Text] [Related]
13. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells. Sharma G, Singh RP, Agarwal R. Int J Oncol; 2003 Nov 15; 23(5):1413-8. PubMed ID: 14532984 [Abstract] [Full Text] [Related]
14. In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C, Agarwal R. Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):244-50. PubMed ID: 14734476 [Abstract] [Full Text] [Related]
15. ErbB kinases and NDF signaling in human prostate cancer cells. Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ. Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997 [Abstract] [Full Text] [Related]
20. Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Agarwal C, Sharma Y, Agarwal R. Mol Carcinog; 2000 Jul 27; 28(3):129-38. PubMed ID: 10942529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]